Neuropsychiatric Complications of Aging with HIV

Overview

Journal J Neurovirol

Publisher Springer

Specialties Microbiology
Neurology

Date 2012 May 31

PMID 22644745

Citations 24

Authors

Crystal C Watkins

Glenn J Treisman

Affiliations

Soon will be listed here.

Abstract

Persons over age 50 are not only aging with human immunodeficiency virus (HIV) infection but also represent a high proportion of new HIV infections. Neuropsychiatric symptoms, including depression, cognitive impairment, and substance abuse, are very common in individuals infected with HIV. However, there is little understanding of the relationship between these HIV-related comorbid conditions in newly infected elderly patients compared to uninfected elderly and those who have survived after 20 years of HIV/AIDS. We summarize the current theories and research that link aging and HIV with psychiatric illnesses and identify emerging areas for improved research, treatment, and patient care.

Citing Articles

White and Gray Matter Changes are Associated With Neurocognitive Decline in HIV Infection.

Chien A, Wu T, Lau C, Pandya D, Wiebold A, Agan B Ann Neurol. 2024; 95(5):941-950.

PMID: 38362961 PMC: 11060903. DOI: 10.1002/ana.26896.

Prevalence of depression and associated factors among HIV/AIDS patients attending antiretroviral therapy clinic at Adama Hospital Medical College, Adama, Central Ethiopia.

Gebru T, Ejara D, Yalew A, Deyessa N Sci Rep. 2024; 14(1):1642.

PMID: 38238489 PMC: 10796940. DOI: 10.1038/s41598-024-52142-z.

Association of depression and antidepressant therapy with antiretroviral therapy adherence and health-related quality of life in men who have sex with men.

Yen Y, Lai H, Kuo Y, Chan S, Chen L, Chen C PLoS One. 2022; 17(2):e0264503.

PMID: 35213633 PMC: 8880848. DOI: 10.1371/journal.pone.0264503.

Older HIV-infected adults: complex patients- geriatric syndromes (II).

Bertagnoli L, Iannuzzi P, Ciccone S, Canevelli M, Marzetti E, Guaraldi G Eur Geriatr Med. 2021; 10(2):213-218.

PMID: 34652755 DOI: 10.1007/s41999-019-00160-w.

Targeting neurotransmitter-mediated inflammatory mechanisms of psychiatric drugs to mitigate the double burden of multimorbidity and polypharmacy.

Matt S Brain Behav Immun Health. 2021; 18:100353.

PMID: 34647105 PMC: 8495104. DOI: 10.1016/j.bbih.2021.100353.

References

Nurutdinova D, Chrusciel T, Zeringue A, Scherrer J, Al-Aly Z, McDonald J . Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 2011; 26(2):229-34. DOI: 10.1097/QAD.0b013e32834e1404. View

Kelly B, Raphael B, Judd F, Perdices M, Kernutt G, Burnett P . Posttraumatic stress disorder in response to HIV infection. Gen Hosp Psychiatry. 1998; 20(6):345-52. DOI: 10.1016/s0163-8343(98)00042-5. View

Kopnisky K, Stoff D, Rausch D . Workshop report: The effects of psychological variables on the progression of HIV-1 disease. Brain Behav Immun. 2004; 18(3):246-61. DOI: 10.1016/j.bbi.2003.08.003. View

Patterson K, Young C, Woods S, Vigil O, Grant I, Atkinson J . Screening for major depression in persons with HIV infection: the concurrent predictive validity of the Profile of Mood States Depression-Dejection Scale. Int J Methods Psychiatr Res. 2009; 15(2):75-82. PMC: 6878440. DOI: 10.1002/mpr.184. View

Perry E, Berman R, Sanacora G, Anand A, Lynch-Colonese K, Charney D . Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. J Clin Psychiatry. 2004; 65(2):238-43. DOI: 10.4088/jcp.v65n0215. View

McArthur J, Brew B . HIV-associated neurocognitive disorders: is there a hidden epidemic?. AIDS. 2010; 24(9):1367-70. DOI: 10.1097/QAD.0b013e3283391d56. View

Perretta P, Akiskal H, Nisita C, Lorenzetti C, Zaccagnini E, DELLA SANTA M . The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients. J Affect Disord. 1998; 50(2-3):215-24. DOI: 10.1016/s0165-0327(98)00111-6. View

Perkins D, Davidson E, Leserman J, Liao D, Evans D . Personality disorder in patients infected with HIV: a controlled study with implications for clinical care. Am J Psychiatry. 1993; 150(2):309-15. DOI: 10.1176/ajp.150.2.309. View

Walkup J, Akincigil A, Hoover D, Siegel M, Amin S, Crystal S . Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia. Public Health Rep. 2011; 126 Suppl 3:89-101. PMC: 3150134. DOI: 10.1177/00333549111260S314. View

10.

Wutoh A, Elekwachi O, Clarke-Tasker V, Daftary M, Powell N, Campusano G . Assessment and predictors of antiretroviral adherence in older HIV-infected patients. J Acquir Immune Defic Syndr. 2003; 33 Suppl 2:S106-14. DOI: 10.1097/00126334-200306012-00007. View

11.

Ickovics J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Boland R . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001; 285(11):1466-74. DOI: 10.1001/jama.285.11.1466. View

12.

Siegel K, Brown-Bradley C, Lekas H . Strategies for coping with fatigue among HIV-positive individuals fifty years and older. AIDS Patient Care STDS. 2004; 18(5):275-88. DOI: 10.1089/108729104323076016. View

13.

DiMatteo M, Giordani P, Lepper H, Croghan T . Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002; 40(9):794-811. DOI: 10.1097/00005650-200209000-00009. View

14.

Koenig L, Pals S, Bush T, Pratt Palmore M, Stratford D, Ellerbrock T . Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008; 27(2):159-69. DOI: 10.1037/0278-6133.27.2.159. View

15.

Lyketsos C, Hanson A, Fishman M, McHugh P, Treisman G . Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence. Int J Psychiatry Med. 1994; 24(2):103-13. DOI: 10.2190/URTC-AQVJ-N9KG-0RL4. View

16.

Elliott A . Anxiety and HIV infection. STEP Perspect. 2001; 98(1):11-4. View

17.

Zanjani F, Saboe K, Oslin D . Age difference in rates of mental health/substance abuse and behavioral care in HIV-positive adults. AIDS Patient Care STDS. 2007; 21(5):347-55. DOI: 10.1089/apc.2006.0043. View

18.

Morrison M, Petitto J, Ten Have T, Gettes D, Chiappini M, Weber A . Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002; 159(5):789-96. DOI: 10.1176/appi.ajp.159.5.789. View

19.

Vance D, Ross J, Moneyham L, Farr K, Fordham P . A model of cognitive decline and suicidal ideation in adults aging with HIV. J Neurosci Nurs. 2010; 42(3):150-6. DOI: 10.1097/jnn.0b013e3181d4a35a. View

20.

Sewell D . Schizophrenia and HIV. Schizophr Bull. 1996; 22(3):465-73. DOI: 10.1093/schbul/22.3.465. View